Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet 349:1498–1504
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078
Musselman DL, Betan E, Larsen H, Phillips LS (2003) Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54:317–329
Talbot F, Nouwen A (2000) A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 23:1556–1562
Rubin RR, Peyrot M (2002) Was Willis right? Thoughts on the interaction of depression and diabetes. Diabetes Metab Res Rev 18:173–175
Willis T (1674) Pharmaceutice rationalis sive diatriba de medicamentorum operationibus in humano corpore. E Theatro Sheldoniano, MDCLXXV, Oxford
Fleiss JL, Gross AJ (1991) Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J Clin Epidemiol 44:127–139
van den Akker M, Schuurman A, Metsemakers J, Buntinx F (2004) Is depression related to subsequent diabetes mellitus? Acta Psychiatr Scand 110:178–183
Arroyo C, Hu FB, Ryan LM et al (2004) Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 27:129–133
Carnethon MR, Kinder LS, Fair JM, Stafford RS, Fortmann SP (2003) Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971–1992. Am J Epidemiol 158:416–423
Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE (1996) Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 19:1097–1102
Everson-Rose SA, Meyer PM, Powell LH et al (2004) Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 27:2856–2862
Golden SH, Williams JE, Ford DE et al (2004) Depressive symptoms and the risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 27:429–435
Kawakami N, Takatsuka N, Shimizu H, Ishibashi H (1999) Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 22:1071–1076
Kessing LV, Nilsson FM, Siersma V, Andersen PK (2004) Increased risk of developing diabetes in depressive and bipolar disorders? J Psychiatr Res 38:395–402
Kumari M, Head J, Marmot M (2004) Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Intern Med 164:1873–1880
Palinkas LA, Lee PP, Barrett-Connor E (2004) A prospective study of type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med 21:1185–1191
Saydah SH, Brancati FL, Golden SH, Fradkin J, Harris MI (2003) Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes Metab Res Rev 19:202–208
Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160:3278–3285
Mulrow CD, Williams JW Jr, Gerety MB, Ramirez G, Montiel OM, Kerber C (1995) Case-finding instruments for depression in primary care settings. Ann Intern Med 122:913–921
Gilbody SM, Whitty PM, Grimshaw JM, Thomas RE (2003) Improving the detection and management of depression in primary care. Qual Saf Health Care 12:149–155
Ramasubbu R (2002) Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypotheses 59:537–551
Genuth SM (1998) The adrenal glands. In: Berne RM, Levy MN (eds) Physiology. Mosby, St Louis, Missouri, pp 930–964
Weber-Hamann B, Hentschel F, Kniest A et al (2002) Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 64:274–277
Bjorntorp P, Holm G, Rosmond R (1999) Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med 16:373–383
Maes M, Minner B, Suy E, Vandervorst C, Raus J (1991) Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia. J Neural Transm Gen Sect 85:195–210
Buckley TM, Schatzberg AF (2005) On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90:3106–3114
Lundberg U (2005) Stress hormones in health and illness: the roles of work and gender. Psychoneuroendocrinology 30:1017–1021
Morris D, Grossman A (2002) The medical management of Cushing’s syndrome. Ann N Y Acad Sci 970:119–133
Ryan MC, Collins P, Thakore JH (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160:284–289
Ayas NT, White DP, Al Delaimy WK et al (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26:380–384
Kawakami N, Araki S, Takatsuka N, Shimizu H, Ishibashi H (1999) Overtime, psychosocial working conditions, and occurrence of non-insulin dependent diabetes mellitus in Japanese men. J Epidemiol Community Health 53:359–363
Meisinger C, Heier M, Loewel H (2005) Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 48:235–241
Nilsson PM, Roost M, Engstrom G, Hedblad B, Berglund G (2004) Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 27:2464–2469
Dentino AN, Pieper CF, Rao MK et al (1999) Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 47:6–11
Kiecolt-Glaser JK, Glaser R (2002) Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 53:873–876
Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9:853–858
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334
Schmidt MI, Duncan BB, Sharrett AR et al (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353:1649–1652
Kaestner F, Hettich M, Peters M et al (2005) Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 87:305–311
Pouwer F, Nijpels G, Beekman AT et al (2005) Fat food for a bad mood. Could we treat and prevent depression in type 2 diabetes by means of omega-3 polyunsaturated fatty acids? A review of the evidence. Diabet Med 22:1465–1475
Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481–486
Hu FB, Manson JE, Stampfer MJ et al (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797
Manson JE, Rimm EB, Stampfer MJ et al (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774–778